Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 15,560 | 13,330 | 11,826 | 10,450 | 12,487 |
| Operating Income | -15,560 | -13,330 | -11,826 | -10,450 | -12,487 |
| Interest Expense | 24 | 35 | 47 | 57 | 70 |
| Other Income | 33 | 33 | 41 | 50 | 79 |
| Pre-tax Income | -15,551 | -13,332 | -11,832 | -10,457 | -12,478 |
| Net Income Continuous | -15,551 | -13,332 | -11,832 | -10,457 | -12,478 |
| Net Income | $-15,551 | $-13,332 | $-11,832 | $-10,457 | $-12,478 |
| EPS Basic Total Ops | -0.47 | -0.42 | -0.38 | -0.48 | -0.71 |
| EPS Basic Continuous Ops | -0.48 | -0.42 | -0.38 | -0.48 | -0.72 |
| EPS Diluted Total Ops | -0.47 | -0.42 | -0.38 | -0.48 | -0.71 |
| EPS Diluted Continuous Ops | -0.48 | -0.42 | -0.38 | -0.48 | -0.72 |
| EPS Diluted Before Non-Recurring Items | -0.49 | -0.42 | -0.38 | N/A | N/A |
| EBITDA(a) | $-15,178 | $-13,004 | $-11,592 | $-10,300 | $-12,345 |